New Advances in the Treatment of Malignant Melanoma

Abstract

This thesis is written to review the new approaches for malignant melanoma. It includes immune checkpoint inhibitors, oncolytic virus therapy, adoptive cell therapy, microbiome therapy, HDAC inhibitors, MCL-1 inhibitors, BRAF kinase inhibitors, MEK inhibitors, DDR inhibitors, and neoantigen vaccines.